EUTOPLAC Topical Probiotic Restores Scalp Microbiome — Reduces Malassezia + Recovers Lactobacillus in Seborrheic Dermatitis

A topical oily suspension containing Lactobacillus crispatus P17631 + Lacticaseibacillus paracasei I1688 (EUTOPLAC) improved seborrheic dermatitis symptoms while reducing Malassezia, decreasing Staphylococcus, and restoring Lactobacillus colonization in Scientific Reports 2024. The data positions direct scalp microbiome modulation as an alternative or complement to antifungal therapy.

The Data

EUTOPLAC trial:

• Strains: Lactobacillus crispatus P17631 + Lacticaseibacillus paracasei I1688
• Format: topical oily suspension
• Target: seborrheic dermatitis patients (scalp)
• Results:
  • Symptom score significantly improved
  • Malassezia (the primary driver) significantly reduced
  • Staphylococcus (secondary infectious source) reduced
  • Lactobacillus + Lacticaseibacillus colonization restored
  • C. acnes propionic acid recovered (microbiome balance)

Conventional treatments (ketoconazole shampoo, selenium sulfide, topical steroids) act via direct antifungal/anti-inflammatory mechanisms. EUTOPLAC works by normalizing the microbiome itself.

Why Scalp Microbiome Drives Seborrheic Dermatitis

Seborrheic dermatitis is not simple dandruff. Malassezia yeast (mainly M. globosa, M. restricta) hydrolyze sebum triglycerides to irritant fatty acids → inflammation + flaking + itch + erythema.

Healthy scalp vs SD microbiome differences:

• Malassezia: patient ↑↑, diversity ↓
• Staphylococcus epidermidis + S. aureus: patient ↑
• Cutibacterium acnes: patient ↓ (propionic acid drop)
• Lactobacillus: patient ↓
• Corynebacterium: patient ↓
• α-diversity: significantly reduced in patients

Eradicating Malassezia alone is not the goal — restoring diversity is the long-term anchor.

Topical vs Oral Probiotics

Topical (EUTOPLAC, Vitreoscilla)

• Direct scalp surface colonization
• Immediate environment shift
• Limited strain delivery
• Oil/lotion application

Oral (Lactobacillus, Bifidobacterium complex)

• Indirect via gut-skin axis
• Immune modulation + systemic anti-inflammation
• Not directly targeting scalp
• 6-12 weeks to effect

EUTOPLAC + oral probiotics = direct + indirect.

Patient Self-Management

Symptom Recognition

• Scalp: yellowish/oily flakes, itch, erythema, thick scales
• Face: T-zone (forehead, nose, brows), nasolabial folds, chin
• Chest/back: white flakes on sebum-rich areas

Triggers

• Stress + sleep deprivation
• Cold dry weather
• Alcohol + high-carb diet
• Steroid rebound
• Immune compromise (HIV, Parkinson’s)

Treatment Approach

1. Antifungal (prescribed): ketoconazole 2% shampoo 2-3x weekly
2. Selenium sulfide 1% shampoo: OTC
3. Zinc pyrithione 1% shampoo: 5 minutes contact, rinse
4. Topical probiotic (EUTOPLAC, others): emerging microbiome-target category
5. Oral antifungal (itraconazole): severe or recurrent
6. Topical short-course steroid: acute flare
7. Topical calcineurin inhibitor (pimecrolimus): face long-term safety

Tone Shift: “Not Eradication, But Balance”

Conventional approach = eradicate Malassezia. But recurrence rates remain high because scalp microbiome diversity stays low. Topical probiotics like EUTOPLAC pursue Malassezia reduction + commensal colonization simultaneously.

K-beauty’s next scalp-care step shifts from antifungal/exfoliant monotherapy to direct microbiome targeting.

Clinical Application

• Topical probiotic: EUTOPLAC or upcoming scalp-targeted LAB products
• Two-shampoo wash: 1st = lather + 5-min scalp massage, 2nd = brief rinse
• Water temperature: lukewarm (hot water = sebum stripping + diversity loss)
• Drying: 100% scalp dry before tying (wet scalp = Malassezia growth)
• Combine probiotic + antifungal: introduce probiotic 1-2 weeks after antifungal
• Avoid: topical probiotic on broken scalp
• Synergy stack: topical probiotic + oral LGG + vitamin D + omega-3 + stress management
• Maintenance: chronic patients benefit from EUTOPLAC or antifungal weekly maintenance therapy